You are here: Industry Insights > endpoint

News List

Nanobiotix soars as late-phase cancer trial hits endpoint fiercebiotech
June 25, 2018
A phase 2/3 trial of Nanobiotix’s NBTXR3 in soft tissue sarcoma has met (PDF) its primary endpoint. The top-line success against the pathological complete response rate endpoint sent Nanobiotix’s stock up by more than 50%.
Crysvita Study Met Primary Endpoint americanpharmaceuticalreview
May 18, 2018
Ultragenyx Pharmaceutical and Kyowa Kirin announced the Phase 3 study of Crysvita (burosumab) met its primary endpoint demonstrating that Crysvita was superior to oral phosphate and active vitamin D (conventional therapy)
EndPoint and SmartAction partner to automate Pharma/ Biotech services europeanpharmaceuticalreview
June 20, 2017
SmartAction and EndPoint Technologies have formed a strategic partnership to expand the availability of AI-powered customer technology.
endpoint’s 500th IRT trial has them looking ahead pharmaasia
February 15, 2017
endpoint’s strategic plan for 2017 emphasizes both technology and infrastructure investments, with a core focus on the growth of its product offerings and geographic footprint.
endpoint selected as sole IRT provider for Ferring Pharmaceuticals AS pharmaasia
February 06, 2017
endpoint has been selected as the sole IRT provider for Ferring Pharmaceuticals AS, a biopharmaceutical company based in Denmark.